Tekturna and White blood cell count increased - a phase IV clinical study of FDA data

Summary:

White blood cell count increased is reported as a side effect among people who take Tekturna (aliskiren hemifumarate), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Aspirin, and have Neuropathy peripheral.

The phase IV clinical study analyzes which people have White blood cell count increased when taking Tekturna. It is created by eHealthMe based on reports of 4,498 people who have side effects when taking Tekturna from the FDA, and is updated regularly.

What is Tekturna?

Tekturna has active ingredients of aliskiren hemifumarate. It is often used in high blood pressure. eHealthMe is studying from 4,730 Tekturna users. Check the latest studies of Tekturna.

What is White blood cell count increased?

White blood cell count increased is found to be associated with 1,788 drugs and 2,649 conditions by eHealthMe. Check the latest studies of White blood cell count increased.

On Aug, 04, 2026

4,498 people reported to have side effects when taking Tekturna.
Among them, 18 people (0.4%) have White blood cell count increased.

Could Tekturna cause White blood cell count increased?

Among these 18 people:

How long have people been on Tekturna when they have White blood cell count increased? *

What is the gender of people who have White blood cell count increased when taking Tekturna? *

female: 50 %
male: 50 %

What is the age of people who have White blood cell count increased when taking Tekturna? *

What are other drugs people take besides Tekturna? *

What are other side effects people have besides White blood cell count increased? *

Blood Glucose Increased: 10 people, 55.56%
Haemoglobin Decreased: 10 people, 55.56%
Pleural Effusion (water on the lungs): 8 people, 44.44%
Blood Urea Increased: 8 people, 44.44%
Blood Creatinine Increased: 8 people, 44.44%
Neutrophil Count Increased (excess than normal number of neutrophil a type of blood cell): 7 people, 38.89%
Blood Calcium Decreased: 7 people, 38.89%
Rashes (redness): 6 people, 33.33%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 5 people, 27.78%
Blood Chloride Decreased: 5 people, 27.78%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 22.22%
Neuropathy Peripheral (surface nerve damage): 4 people, 22.22%
Cardiac Failure Congestive: 3 people, 16.67%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 3 people, 16.67%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 11.11%
Urinary Tract Infection: 1 person, 5.56%
Gout (uric acid crystals building up in the body): 1 person, 5.56%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 5.56%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 5.56%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Tekturna and have White blood cell count increased?

- Check whether White blood cell count increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tekturna:

Tekturna (4,730 reports)

Browse all side effects of Tekturna:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with White blood cell count increased:

White blood cell count increased (1,788 drugs)

Browse all the conditions that are associated with White blood cell count increased:

White blood cell count increased (2,649 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aliskiren hemifumarate (the active ingredients of Tekturna) and Tekturna (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.